@misc{indiciae57131a293d58,
  title = {Preclinical trial supports dual inhibition of BCL2 and Aurora kinase A for MYCN-amplified high-risk neuroblastoma},
  author = {Kamili, A. and Hearn, B. A. and Temelkoska, I. and Solomon, J. and Wheatley, M. S. and Bui, C. H. T. and Atkinson, C. J. and Elhassadi, L.-J. and Qureshi, S. and Murray, J. and Cadiz, R. and Gifford, A. J. and Cui, L. and Crowley, L. and Lin, A. and Mayoh, C. and Wong-Erasmus, M. and Failes, T. W. and Arndt, G. M. and Haber, M. and Norris, M. D. and Dolman, M. E. M. and Trahair, T. N. and Fletcher, J. I.},
  year = {2026},
  doi = {10.64898/2026.09.06.749004},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.06.749004v1},
  note = {Source identifier: 10.64898/2026.09.06.749004}
}